<bill session="110" type="h" number="1277" updated="2023-01-11T19:56:18Z">
  <state datetime="2007-03-01">REFERRED</state>
  <status>
    <introduced datetime="2007-03-01"/>
  </status>
  <introduced datetime="2007-03-01"/>
  <titles>
    <title type="official" as="introduced">To direct the Secretary of Health and Human Services to investigate how to eliminate the gap in benefits between standard coverage and catastrophic coverage under the Medicare prescription drug program under part D of title XVIII of the Social Security Act.</title>
    <title type="display">Medicare Prescription Drug Benefits Gap Elimination Act of 2007</title>
    <title type="short" as="introduced">Medicare Prescription Drug Benefits Gap Elimination Act of 2007</title>
  </titles>
  <sponsor bioguide_id="B001251"/>
  <cosponsors>
    <cosponsor bioguide_id="B001227" joined="2007-03-01"/>
    <cosponsor bioguide_id="C000380" joined="2007-03-01"/>
    <cosponsor bioguide_id="G000553" joined="2007-03-01"/>
    <cosponsor bioguide_id="J000255" joined="2007-03-01"/>
    <cosponsor bioguide_id="M001137" joined="2007-03-01"/>
    <cosponsor bioguide_id="M001154" joined="2007-03-01"/>
    <cosponsor bioguide_id="U000038" joined="2008-04-16"/>
    <cosponsor bioguide_id="W000792" joined="2007-03-01"/>
    <cosponsor bioguide_id="W000784" joined="2007-03-01"/>
  </cosponsors>
  <actions>
    <action datetime="2007-03-01">
      <text>Introduced in House</text>
    </action>
    <action datetime="2007-03-01" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2007-03-01">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2007-03-05">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2007-03-07">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Drugs"/>
    <term name="Governmental investigations"/>
    <term name="Legislation"/>
    <term name="Prescription pricing"/>
    <term name="Social Welfare"/>
  </subjects>
  <amendments/>
  <summary date="2007-03-06T16:28:37Z" status="Introduced in House">Medicare Prescription Drug Benefits Gap Elimination Act of 2007 - Directs the Secretary of Health and Human Services to study and report to Congress on how to eliminate the gap in benefits for covered part D drugs under the Medicare prescription drug program under Medicare part D (Voluntary Prescription Drug Benefit Program) of title XVIII of the Social Security Act after a part D eligible individual's costs exceed the initial coverage limit, and before the individual obtains protection against high out-of-pocket expenditures.</summary>
</bill>
